Why Do Testosterone Pellets Extrude After Insertion?

Why Do Testosterone Pellets Extrude After Insertion?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Already a member? Sign In

Timeline

00:00

A healthcare provider asks about pellet extrusion approximately two months after insertion. Dr. O’Connor discusses possible patient and placement factors while acknowledging that extrusion can occur despite appropriate technique.

02:00

Dr. O’Connor questions pellet use in active men and discusses injections, oral testosterone undecanoate, and gel. He introduces the risk of gel transfer and recounts a child’s reported exposure through close contact with his father.

05:30

The discussion returns to pellet alternatives and testosterone delivery patterns. Dr. O’Connor favors smaller, more frequent testosterone enanthate injections and expresses reservations about pellets, widely spaced injections, and long-acting injectable testosterone undecanoate.

07:30

Dr. O’Connor broadens the discussion to cardiovascular, hematologic, and psychiatric care. He emphasizes managing treatment complications and distinguishes testosterone-associated erythrocytosis from polycythemia vera.

09:30

The focus shifts to prescriber responsibility and potential consequences when testosterone-related problems are inadequately managed. Dr. O’Connor discusses serious psychiatric and cardiovascular events and emphasizes continued involvement in patient care.

11:10

Dr. O’Connor returns to practical monitoring of red blood cells, blood pressure, and cholesterol. He cautions against reflexive phlebotomy and emphasizes the training and commitment needed to manage testosterone treatment.

Video Summary

Testosterone pellets can extrude after insertion, prompting questions about technique, patient factors, and alternative delivery methods. A healthcare provider asks why some patients expel pellets approximately two months after placement. Dr. O’Connor acknowledges that he cannot identify the exact cause and discusses possible contributions from skin characteristics, body habitus, placement, and activity.

He emphasizes that extrusion can occur even when a skilled clinician performs the procedure correctly. He expresses a preference for injectable testosterone in his male patients and discusses oral testosterone undecanoate as another option when pellets are unsuitable.

Testosterone gel introduces a different concern: unintended transfer to other people. Dr. O’Connor recounts a man in his 50s whose young child reportedly developed precocious puberty after exposure to his testosterone gel during close contact. The story illustrates why household circumstances and counseling matter when selecting a delivery method.

Returning to the provider’s question, Dr. O’Connor favors smaller, more frequent testosterone enanthate injections over widely spaced injections. He criticizes fluctuations associated with some regimens and expresses reservations about pellets and long-acting injectable testosterone undecanoate. These comments reflect his clinical preferences rather than an individualized prescription.

The discussion broadens to the responsibilities of testosterone prescribers. Dr. O’Connor emphasizes cardiovascular, hematologic, and psychiatric considerations, including erythrocytosis, blood pressure, cholesterol, and mood-related problems. He distinguishes testosterone-associated erythrocytosis from polycythemia vera and cautions against reflexive referrals and repeated phlebotomy without understanding the clinical picture.

He closes by emphasizing ongoing monitoring, appropriate collaboration, and clinician training. His central message is that choosing a testosterone delivery method must be accompanied by the ability to recognize and manage its complications.

Drug Callouts

Testosterone Pellets

Testosterone pellets are implanted hormone preparations discussed in relation to extrusion after insertion. Dr. O’Connor acknowledges uncertainty about the cause in these patients and expresses a preference for other delivery methods in his male practice.

Testosterone Gel

Testosterone gel is discussed as a transdermal option with the potential for unintended transfer during close contact. Dr. O’Connor recounts a child’s reported exposure and emphasizes considering household circumstances when selecting treatment.

Testosterone Enanthate

Testosterone enanthate is the injectable formulation Dr. O’Connor favors in this discussion. He advocates smaller, more frequent injections rather than widely spaced administration and discusses patient education for self-injection.

Testosterone Undecanoate

Dr. O’Connor mentions oral testosterone undecanoate as an alternative when pellets are unsuitable. He separately expresses reservations about long-acting injectable testosterone undecanoate, distinguishing the oral and injectable delivery options.

Condition Callouts

Pellet Extrusion

Pellet extrusion is the expulsion of an implanted pellet through the skin. For men receiving testosterone pellets, Dr. O’Connor discusses possible patient, placement, and activity factors and notes that extrusion does not automatically establish poor technique.

Precocious Puberty

Precocious puberty is discussed in a child reportedly exposed to his father’s testosterone gel. For men using topical testosterone, this illustrates a potential consequence of unintended household exposure rather than a condition diagnosed in the testosterone user.

Erythrocytosis

Erythrocytosis involves increased red blood cells and is discussed as a complication of testosterone treatment. For men on testosterone or anabolic steroids, Dr. O’Connor emphasizes appropriate evaluation and management rather than automatic repeated phlebotomy.

Polycythemia Vera

Polycythemia vera is discussed as a diagnosis distinct from testosterone-associated erythrocytosis. For men using testosterone or anabolic steroids, Dr. O’Connor cautions against assuming that treatment-related red blood cell elevations represent this separate disease.

Hypertension

Elevated blood pressure is discussed as a problem testosterone prescribers must recognize and manage. For men on testosterone or anabolic steroids, Dr. O’Connor emphasizes continued monitoring and clinician responsibility for addressing changes.

Mood Disorders

Mood disorders are discussed as part of the psychiatric considerations surrounding testosterone treatment. For men using testosterone or anabolic steroids, Dr. O’Connor emphasizes that care must include attention to mood and behavior as well as hormone delivery.

Key Takeaways

Pellet extrusion can occur despite appropriate technique; the cause in an individual patient requires assessment.
Dr. O’Connor favors injectable testosterone for his male patients and discusses alternatives when pellets are unsuitable.
Testosterone gel can expose household contacts through unintended transfer, making counseling and delivery-method selection important.
Dr. O’Connor prefers smaller, more frequent testosterone enanthate injections over widely spaced regimens in this discussion.
Testosterone-associated erythrocytosis should be distinguished from polycythemia vera before choosing a management approach.
Testosterone care requires ongoing attention to red blood cells, blood pressure, cholesterol, mood, and treatment complications.